Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, et al. Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial. Lancet Gastroenterol Hepatol 2020 Oct 5. pii: S2468-1253(20)30301.
PMID: 33031757